glp-1 r retatrutide Triple Agonist Peptide | cGMP Retatrutide (GLP-3)

Moore also believes that slower, more sustainable weight loss allows the body more time to adjust to changes in weight, reducing the side-effect profile and potentially leading to better long-term success

This two-sided energy balance approach is mechanistically unique to the triple agonist class

This is where Pillo can quietly help

Without insurance, the price can vary from $149-299 for the pill, and $199-499 per month for the pen, depending on the dose

Although no data from head-to-head trials comparing retatrutide to other currently approved obesity treatments exist, data from the phase 2 studies with retatrutide suggest that at higher doses, retatrutide could lead to greater WL compared to the most efficacious approved treatments for obesity and T2D such as tirzepatide 15 mg and semaglutide 2.4 mg (Fig